This document is an excerpt from the EUR-Lex website
Document 22013D0189
Decision of the EEA Joint Committee No 189/2013 of 8 November 2013 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 189/2013 of 8 November 2013 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 189/2013 of 8 November 2013 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
IO L 92, 27.3.2014, p. 15–15
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
Relation | Act | Comment | Subdivision concerned | From | To |
---|---|---|---|---|---|
Modifies | 21994A0103(52) | Cur le | caibidil XIII pointe 13 fleasc | 09/11/2013 |
27.3.2014 |
EN |
Official Journal of the European Union |
L 92/15 |
DECISION OF THE EEA JOINT COMMITTEE
No 189/2013
of 8 November 2013
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
(1) |
Commission Implementing Regulation (EU) No 59/2013 of 23 January 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance monensin (1) is to be incorporated into the EEA Agreement. |
(2) |
Commission Implementing Regulation (EU) No 115/2013 of 8 February 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance diclazuril (2) is to be incorporated into the EEA Agreement. |
(3) |
Commission Implementing Regulation (EU) No 116/2013 of 8 February 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance eprinomectin (3) is to be incorporated into the EEA Agreement. |
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following indents are added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement:
‘— |
32013 R 0059: Commission Implementing Regulation (EU) No 59/2013 of 23 January 2013 (OJ L 21, 24.1.2013, p. 21), |
— |
32013 R 0115: Commission Implementing Regulation (EU) No 115/2013 of 8 February 2013 (OJ L 38, 9.2.2013, p. 11), |
— |
32013 R 0116: Commission Implementing Regulation (EU) No 116/2013 of 8 February 2013 (OJ L 38, 9.2.2013, p. 14).’ |
Article 2
The texts of Implementing Regulations (EU) No 59/2013, (EU) No 115/2013 and (EU) No 116/2013 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 9 November 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 8 November 2013.
For the EEA Joint Committee
The President
Thórir IBSEN
(1) OJ L 21, 24.1.2013, p. 21.
(*1) No constitutional requirements indicated.